Measurements of whole-body protein turnover in preterm infants have been made using different stable isotope methods. Large variation in results has been found, which could be due to different clinical conditions and/or the use of different tracers. We studied 14 appropriate for gestational age and nine small for gestational age orally fed preterm infants using ['"]glycine and [l-"C]leucine simultaneously, which allowed us to make a comparison of commonly used methods to calculate whole-body protein turnover. Whole-body protein turnover was calculated from '% enrichment in urinary ammonia and urea after [I5N]-glycine administration and from the "C enrichment in expired CO, after administration of [l-'"]leucine.
The use of stable isotopes for measuring metabolic processes in vivo has a clear ethical advantage over radioactive isotopes. The nonradioactive character allows their use in pregnancy and in infants. Schoenheimer et al.
(1) used stable isotopes to study protein turnover as early as 1939, but more extensive research has been done since the 1970s, when analytical techniques improved remarkably (2) . From then onward, numerous protein turnover studies have been performed using stable isotopes, in adults as well as in children. 15~-labeled amino acids have been favored for many years in preterm infants because of the noninvasive character of the studies. The method allows I Manuscriut dedicated to Professor M. K between leucine oxidation and total nitrogen excretion. We found very low '% enrichment of urinary urea in the majority of small for gestational age infants. These infants also had a lower nitrogen excretion in urine and oxidized less leucine. Nitrogen balance was higher in small for gestational age infants (41 6 ? 25 mg.kgP1.dP') compared with appropriate for gestational age infants (374 ? 41 mg.kgP'.dP', p = 0.003).
[I5~]Glycine does not seem to exchange its label with the body nitrogen pool to a significant degree and is therefore not always suitable as a carrier for 15N in protein turnover studies in premature infants. (Pediatr Res 37: 381-388, 1995) Abbreviations AGA, appropriate for gestational age SGA, small for gestational age KICA, ketoisocaproic acid IRMS, isotopic ratio mass spectrometer quantification of protein metabolism by measurement of isotope enrichment in an end product of protein catabolism in urine (3) (4) (5) (6) (7) (8) (9) (10) . [1 -l"]~eucine, another stable isotopic labeled tracer, has been used for protein studies in preterm neonates more recently, with either the measurement of isotopic enrichment of [l-13~]leucine or [ ' 3~]~-~~~~ in urine (11, 12) or plasma (13) (14) (15) (16) (17) . The different tracers give different results, i.e. for whole-body protein synthesis, rates ranging from 5 g.kg-l.d-' to 26 g.kg-'.d-' have been reported, depending on clinical and experimental conditions (3, 14) . Studies were performed comparing different tracers and amino acids in adults (18) and in term infants (19) or comparing different amino acids with a similar label (8, 9, 20) . However, to date there are no studies comparing the two most commonly used labeled amino acids, [I5~lglycine and [l-'%]leucine, in preterm neonates. VAN 
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The aim of the present study was to mcasure the protein turnovcr rates in orally fed, growing prctcrm infants using [ ' 5~] g l y c i n e and [ l -' i~] l c u c i n c simultaneously with mcasuremcnt of enrichment in urinary NH, and urea, plasma KICA, ~uid cxpircd CO,.
METHODS
Patients
Twenty-three stable, growing pretcrm infants were studied (Table I) . SGA infants were defined as infants with a birth weight more than 2 SD below the mean birth weight for gestation, whereas A G A infants had a birth weight between -2 SD and +2 SD according to the charts of Usher and Mclean (21) . Gestational age was determined by maternal history and Ballard score (22) . At the timc of the study, the infants had been fed for at least 1 wk a preterm formula (Nutricia, Zoetcrmccr, The Netherlands) and were on full enteral feedings for at least 3 d. A s this study is part of a larger study that determines metabolic cKccts of ditferclit cncrgy intakes, infants were fed either a formula containing SO kca1/100 m L or 67 kcall100 mL. The protein content of both formulas was equal, 2.2 gI100 mL.
Informed consent from the parents was obtained in all cases, and the study had tlic approval of the local ethics committee.
Procedures
Seventy-two-hour nitrogcn balance and ['"lglycine wholebody protcin turnovcr studies were carried out by collection of urine in 3-h periods using adhesive bags. Urine was put directly in -20°C, until analysis. During this period, the feeding was given in a semicontinuous mode (every 1 5 min an aliquot of formula) through a nasogastric tube. ["N]Glycinc (99 atom% excess "N, MSD, Montreal, Canada) was given in hourly intervals at a dosage of 3 m g of [ "~] g l y c i n c . k g~' . d~' through the nasogastric tube. Analysis of "N cnrichment of urinary ammonia and urea and total nitrogen excretion was performed as previously described (10) . Visual inspection was used to determine at what timc a plateau was reached. The height of thc plateau (delta enrichment) was then calculated by substracting thc basal cnrichment from tlic mean enrichment of at least five points (= 15 11) at plateau. Nitrogcn losses in the stools and through the skin were assumed to be 10% of the intake (23) (24) (25) (26) .
On the second day of the [ ' i~] g l y c i n c turnover study and the nitrogen balance, a primed constant oral infusion of [~-'~~] l e u c i n c (priming dose 2 m g . k g -' , continuous 2 n1g.kgp ' .hp ', 99 atom% excess 13C, Isotech, Miamisburg, OH), with an additional priming of the bicarbonate pool with 6.9 pmollkg ' 3~-l a h c l c d sodium bicarbonate (99 atom% cxccss l3C, Isotech), was administered for 4 h, using a Harvard infusion pump (M22, Harvard Apparatus Co. Inc., South Natick, MA). The formula was also administered continuously during this pcriod. The infants were nursed in a closed circuit indirect calorimetry incubator during the [I-"C]leucine turnover study. Rate of CO, excretion was mcasured and cxpircd air was collcctcd bcfore and during the [l-leucin cine administration by passing a sample of air leaving the calorimeter through an all-glass spiral condenser, containing 1 0 m L of a fresh 1 M NaOH solution (27) . After liberating CO, by adding phosphoric acid (85%) to the solution, the '%o,/'~co, isotope ratio was measured on an isotope ratiolmass spectrometer in Rotterdam, the Netherlands (SIRA 10, VG, Winsford, Cheshire, UK).
Three blood samples were drawn, onc before the start of the study, and two at the end of infusion of [1-'"]leucine with a 15-min interval. Within 15 min, plasma was stored at -70°C until further analysis. The plasma enrichment of KICA was measured by gas cliromatography/mass spectrometry with electroll impact and selected ion monitoring in Harrow, UK (28) .
Calculations
Required assumptions and the calculations to provide wholebody protein turnover rates by methods frequently reported in the literature are briefly presented. Their relative merits will be discussed later.
There are in general two methods to calculate whole-body protein turnover with stable isotope labeled tracers, either using I) enrichment in end products or 2 ) the direct measurement of the plasma enrichment of an essential amino acid. The former is based on measurement of labeled urea and ammonia as end products of protein metabolism in '%-tracer studies or on the excretion of I3C0, in expiratory air that is formed at the decarboxylation step as a function of oxidation in '"-tracer studies. Direct measurement of the dilution of a tracer is usually performed in plasma or urine. Leucinc is an essential amino acid that is very often used to assess protein turnover with a direct measurement in plasma (13) .
End products and [ ' "~]~l~c i n e .
Calculation I . The measurement of protein turnover using ['%]urea enrichment in urinc relies on the concept that there is a single homogenous pool of metabolically active nitrogen in the body (1). "N enters this pool by means of 'sN-labelcd glycine and is freely exchanged between other amino acids. The incorporation of nitrogen into protein and urea is assumed to arise from the same precursor pool. Nitrogcn flux (Q) through this pool is calculated by dividing tlic amount of adrninistcred tracer (d) by the cnrichment in urea (IE,,,,,,) (2). This simple model is one of the most commonly used methods for studying protein metabolism in preterm neonates.
C~llculation 2. The measuremcnt of protein turnover using 1 5~-a m m o n i a enrichment in urinc is identical to the one described above, with the only difference of the measuremcnt of enrichment in urinary ammonia instead of urea.
Calculation 3. The single pool model, as used in calculations 1 and 2, was questioned because of the differences found in enrichment of urea and ammonia (29, 30) . The next simplest model with the use of end products is the concept of two compartments, from which either urea or ammonia arises. Different mathematical estimates of protein turnover can be obtained using different assumptions regarding flux rates through the compartments and partitioning of the tracer. Assuming an equal partitioning of the tracer dose between the two metabolic compartments, the nitrogen flux equals the arithmetic average of the values for flux obtained individually.
Calculation 4.
An alternative method to calculate wholebody protein turnover rates based on both urea and ammonia enrichment is by using the harmonic mean. The basic assumption in this calculation is that the nitrogen flux through the pool from which urea is derived is similar to the nitrogen flux through the pool from which ammonia is derived, in equation:
An IRMS is required to measure the 15N enrichment in urinary ammonia and urea. When using the recovery of label in expiratory air during administration of [1-'%]leucine for calculating whole-body protein turnover, one assumes that the ratio of oxidation of leucine (EL) to total body protein oxidation (EN) is equal to the ratio of dietary intake of leucine (I,) to dietary intake of protein (I,) (18, 19) . In equation:
Total body protein oxidation is measured by the nitrogen excrction (E,). Inasmuch as intake of leucine and total amount of nitrogen in the diet can be calculated from the composition of the formula and the nitrogen excretion can be measured in the urine, the total amount of leucine oxidized can be calculated.
Leucine oxidation also equals the leucinc flux times the recovery of label in expiratory air. The equation used for the oxidation is:
where Vco, is the rate of CO, excretion in pmol.kgp'.min-' during the [l-13~]leucine infusion, IE,,? is the isotopic enrichment of expired CO, at plateau, I is the [1-leucin cine infusion rate in micromoles of [13~].kg-'.minp1, and c i s the correction factor for bicarbonate retention calculated from the energy intake (31) . If the leucine oxidation is derived from equation 5, and recovery of the label in expiratory air (the first part of equation 6) is measured, an estimate of leucine turnover can be calculated as leucine oxidation divided by recovery of the labcl. Whole-body protein turnover can bc calculated assuming that 590 pmol of leucine represent 1 g of protein (32) . Analogous to the measurement of I5N enrichment in urea or ammonia, the "C enrichment in expiratory air requires an IRMS as well.
Direct measurement and [l-'3~]leucine. Cczlc~llntion 6. With the infusion of [l-13~]leucine and the measurcrnent of labeled a-KICA, one applies the reciprocal pool model to calculate whole-body protein turnover (33, 34) . The dilution of the tracer in plasma is an estimate of the turnover of the amino acid, in equation:
where i is the [l-l"]leucine infusion rate (pmol.kg-'.lip'), E, is the isotopic enrichment of the [1-'"]leucine infused (atom% excess), and E, is the isotopic enrichment of a-KICA in plasma. Leucine flux is extrapolated to whole-body protein turnover using again the assumption that 1 g of protein contains of 590 pmol of leucine.
The 13C cnrichment of a-KICA is measured by a gas chromatograph mass spcctrometer. To calculate whole-body protein synthesis and breakdown from whole-body protein turnover the equation used is Assuming a constant pool size, nitrogen leaving thc pool [for protein synthesis (S) and urinary excretion (E)] should equal nitrogen entering the pool [from dietary intake (I) and from protein breakdown (B)]. With thc measurement of total nitrogen excretion and nitrogen intakc, both synthesis and breakdown rates can be obtained if the flux (Q) is known. Valucs for whole body protein are calculated by multiplying the nitrogcn data by a factor of 6.25.
Calcillation 7. If one does not want to extrapolate to wholebody protein rates, other terms arc used that are directly derived from data obtained by leucine turnover studies. Nonoxidative disposal (NOD, a measure of protein synthesis) and leucine released from proteins (LRP, a measure of protein breakdown) can be calculated according to the following cquation:
Again, these leucine turnover rates can be extrapolated to whole-body protein turnover rates (28) . It is not needed to measure nitrogen excretion using this calculation. Both an IRMS and a gas chromatography mass spectrometry are needed to measure the '% enrichment in expiratory air and the I3C enrichment in a-KICA, respectively. of' ~vhole-body prolein ,$~tx, protein .syntlzesis, utzd proteiti I?t,eakdo~vn estirnntecl ,fi-orn cl(fererzt tracers and ccl1cllltrlion .s :': Dilfercricc at P < 0.05 between calculation 3 11.r 6 and 7.
.f Significant ditfcrcnce between AGA and SGA infants at P < 0.05. $Significant dilfcrcnce hetwccn calculation 5 and the others at P < 0.0001.
Table 3. Relative l~ercetittrge of proteiti i~~rtlover arid correlntions between protein tltnzover in iizr~ivitl~~nl l~~rtietit.c
- - - ~p -- - - -~p -- - --- .-
Spearman rank correlation coeflicicnt
Relative protein turnover in percentages (x i SEM)
The relative pcrccntage of protein turnover (xly) is depicted in the left lower half of the table, the correlations hetwccn protein turnovcr in individual patients (Spearman) are shown in the upper right half of the table.
'"ignilicancc at P < 0.05. leucine is an essential amino acid, it is assumed that the rate of appearance of leucinc (a-KICA) is a reflection of release of all amino acids from body proteins, because thcre is no de rzovo synthesis of Ieucine. Both methods have their limitations.
Glycine. Thc [ l S~] g l y c i n e method assumes that the total active body pool of amino acids consists of one or two metabolically active pools from which urea and ammonia are derived. The label "N enters the pool and is assumed to be rapidly exchanged bctween all metabolically active amino acids. Urea and ammonia are assumed to be arising from this pool. Urea is syllthesized in the liver via the urca cycle (35) . Nitrogen enters this cycle by carbamoylphosphate and aspartate. Nitrogen for aspartate arises from the a amino group of groups of glutamine and asparagine or by degradation reactions of serine, threonine, histidine, glycine, and methionine. Ammonia from the bacterial decomposition of urca in thc g~~t can also be a significant precursor. Glutamate receives its nitrogen from the majority of amino acids, but not from glycine and serine, during the following rapid conversion that is mediated by glutamate transaminase: a-amino acid + a-ketoglutarate a-keto acid + glutamate. Nitrogen in the urea molecule could therefore be derivcd from many different amino acids.
Glycine and serine are readily transformed into one another. In addition glycine may arise from threonine by a specific aldolase enzyme or from choline. However, the two last pathways are not likely to be quantitatively important (36) . Glycinc does not transaminate with glutamate as shown by Jackson and Golden (37) who observed no enrichment of glutamate during continuous infusion of [ "~~g l y c i n e .
Howevcr, Matthews et nl. (38) showed labeled nitrogcn in glutamate after [l%]glycine administration, but a majority of the amino acids were not significantly enrichcd. Nitrogen (labeled) from glycine will probably not exchange to a great extent with a large group of amino acids via transamination that is considered to be a major pathway for rapid nitrogen transfer. For these reasons, doubt 386 VAN GOUDOEVER ET AL.
can be raised whether glycinc is a suitable carrier to introduce labeled nitrogen in the metabolic nitrogcn pool.
Glycine is deaminatcd via the glycine cleavage system, with the releasc of free ammonia (39) . Duda and Handler (40) showed that free ammonia is considerably more rapidly incorporated into the amide position of glutamine than into any othcr nitrogenous component of liver. After administration of amide N-labclcd glutamine, the isotope appeared only slowly in urca or glutamic acid. Other studies have shown that urinary ammonia is mainly produced from the amide N of glutamine in the kidney (41) (42) (43) . A rapid transfer of glycine nitrogen to urinary ammonia via glutamine is therefore to be cxpected as was observed in both SGA and AGA infants in the present study. The question remains why we did not find enrichment of urinary urea in SGA infants.
SGA infants had lower rates of urinary nitrogen excretion, of which urea is the major component, suggesting that the urea synthesis rate was lower in this group. Regulation of the urea production might be a nitrogen conservation mechanism, occurring to a greater extent in SGA infants than in AGA infants. This hypothesis is supported by the indices of protein turnovcr. The cfficiency of protein gain (leucine retention divided by leucine turnover) was significantly higher in infants who showed low urea enrichments [21 + 11% (low urea enrichment) vel-sus 10 +-8% (platcau in urea enrichment), p = 0.031. This is in accordance with the original work of Picou and Taylor-Roberts (2), who also showed a higher protein synthesislprotein turnover (SIQ) ratio in malnourished patients, and also in accordance with Cauderay et al. (44) who showed a more efficient protein gainlprotein synthesis ratio in SGA infants. In this context, SGA infants can also be considered as malnourished infants. Pencharz et nl. (459, however, reported similar SIQ ratios in SGA and AGA infants. Cauderay et al. used ['%]glycine, but reported significant urinary urea enrichments in all SGA infants in contrast to the findings in the present study. However, they administered very large amounts of [L%]glycine, 30 mg.kg-'.dl, which is no longer a tracer dose and may have resulted in an overload of glycine.
Glycinc is a major component of heme and is also important for purine synthesis, whercas carbamoyl phosphate and aspartatc, both urea cycle intermediates, are used for the synthesis of pyrimidincs. With an increased need for those components, a large part of label could follow that pathway with a resulting low enrichment of urea. Purines are degraded to uric acid and with the degradation of pyrimidines, the amino group will be removed by transamination.
In conclusion, we can assume that ammonia and a significant part of urea nitrogen arise from very different pools of amino acids, and it is therefore not surprising that differences are obtained using both methods as has been suggested by Waterlow er al. (46) . Averaging the results obtained via ammonia and urea enrichment, as is done in calculation 3 and 4, is likely to be incorrect as wcll for the same reasons as discussed above. The original concept of rapid exchange of the nitrogen of glycine with othcr amino acids does not appear to be valid, suggesting that protein turnover as assessed by [ '~] g l y c i n c is unlikely to accurately rcpresent whole-body protein turnover.
Leucine. The original model for quantification of leucine kinetics assumes a single pool from which leucine is used for protein synthesis and into which it enters from protein breakdown. Lcucine turnover rate is calculated from the isotope dilution of the labeled leucine in plasma. The fundamental problem with this model is that the leucine tracer is infused into and sampled from plasma, whereas it is metabolized within the cells. Because lcucine is transaminated reversibly within the cell to a-KICA, the enrichment of a-KICA reflects the intracellular enrichment of leucinc (47) . Recent animal studies have shown a very good agreement of plasma a-KICA enrichment and intracellular leucine enrichment (48, 49) . The enrichment of a-KICA after [1-'3~]leucine infusion seems therefore a good reflection of the precursor pool for protein synthesis within the cell. Recent studies have shown that a multipool model gives the best fit for the intracellular turnover. The multipool model demands, however, many sample points and is therefore hardly feasible in premature infants. In specific circumstances thc reciprocal pool model has found to be in good agreement with a seven-pool model that can be constructed from simultaneous infusion of labeled leucine and a-KICA (50, 51) . It is unclear whether data obtained for leucine kinetics can be extrapolated to whole-body protein turnovcr, synthesis, and breakdown, because leucine is predominantly metabolized in the muscle, and therefore may not be the best representative of protein metabolism in other organs. However other amino acids like tyrosine are metabolized mainly in the liver and will therefore not rcpresent muscle protein metabolism. In general we can state that no single amino acid will represent whole-body protcjn turnover because whole-body protein consists of heterogenous pools of amino acids with diffcrent rates of turnover and possibly different amino acid composition.
Comnparisorz of calculations. From the above it is clear that a comparison of methods, to decide which of the methods is "best," may not be meaningful, because calculations based on enrichment of urea, ammonia, and a-KICA are reflections of different processcs.
The end product method of estimation of whole-body protein turnover from urinary nitrogcn excretion and from expiratory CO, after [l-'"]leucine administration (calculation 5) gave rcsults that were significantly lower compared with all the other calculations. This calculation assumes a correlation between leucine oxidation and nitrogen excretion in urine. We measured the leucine oxidation quantitatively and found that the leucine oxidation did not correlate with the urinary nitrogen excretion. Hence, this calculation is not suitable for the estimation of whole-body protein turnover in this group of patients, although it has been used in preterm infants (19) and elderly patients (18) . The total amount of leucine oxidation could be influenced by the diet, because the leucine concentration of the protein in the diet exceeded the leucine tissue concentration in our study. This could have led to an increased leucine oxidation, but not to a difference in oxidation between AGA and SGA infants because both groups received the same amount of protcin.
Although most group means were not significantly diffcrent, the turnovcr rates obtained by measurement of plasma a-KICA enrichment (calculations 6 and 7) were higher than the other rates. The duration of tracer administration is much shorter compared with the duration of ['%]glycine administration. Recycling of the tracer in the latter experiments could increase the enrichment, with a corresponding lower turnover rate. Estimation of recycling of ['%]glycine by Cauderay et 01. (44) was 20% after 72 h of infusion, whereas Schwenk et 01. (52) calculate 30% recycling of a labeled essential amino acid after 24 h of infusion.
Methodology. Some methodologic questions can be raised regarding the present study. First, a plateau in KICA enrichment cannot be defined on two blood samples. However, we found it unethical to take more than three blood samples from premature infants just for study purposes. Furthermore, we found a plateau in enrichment of expiratory CO,, which means a plateau in enrichment of the precursor of CO,, KICA.
Second, urine collection via bags might be a source of error in measuring nitrogcn excretion. However, by measuring the change of weight of every diaper, it is possible to extrapolate the measured nitrogen content of the collected urine to the total urine production to calculate the total urinary nitrogen excretion. A source of error in calculated urinary nitrogen excrction would affect only the results of calculation 5, because this calculation is dependent on nitrogen excretion for calculating protein flux. Direct measurements of tracer dilution are used in all other calculations, which makes model dependent issues more likely to explain the differences found in protein fluxes.
Route of tracer admiizistration. In this study, we administered the tracer by the same route as the feed. Some considerations have to be made when using intragastric infusion of label. The intestinal absorption must be known. The ['%lgly-cine excretion in feces has been measured before and is 0.3-3% of the intake (2, 8) . Another possible confounding factor is the uptake in the splanchnic area. With a considerable uptake of tracer and tracee in the splanchnic area, the amount of tracer that reaches the circulation is reduced. Subsequently, this amount is more easily diluted by the systemic flux, resulting in a lower enrichment. Both protein turnover and protcolysis could therefore be ovcrestimatcd.
Corzclusiorzs. In SGA infants, urinary ammonia becomes enriched after continuous administration of [l%]glycine. Urinary urea shows hardly any enrichment, which might be d~~e to a decreased rate of label transfer from glycinc to urea. This suggests a protein-sparing mechanism in SGA infants that is supported by a decreased nitrogen excrction and a decreased leucine oxidation found in this group of infants. Group averages for whole-body protcin turnover in orally fed preterm infants ranged between 10 and 14 g . k g -' . d l , except for the calculation based upon a correlation of leucine oxidation and nitrogen excrction. Leucine oxidation is not correlated with nitrogen excretion. We found no correlation between wholebody protein turnover measurements with [ l 5~] g l y c i n c or [1-"Cllcucine within individual patients.
